Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$577K Hold
4,800
0.32% 45
2025
Q4
$505K Hold
4,800
0.31% 43
2025
Q3
$403K Sell
4,800
-193
-4% -$15.9K 0.26% 48
2025
Q2
$395K Hold
4,993
0.3% 45
2025
Q1
$448K Buy
4,993
+1,600
+47% +$149K 0.36% 43
2024
Q4
$338K Buy
+3,393
New +$350K 0.31% 42

Other funds holding MRK

Elefante Mark B's MRK Position: Q1 2026 in Review

Elefante Mark B held its Merck (MRK) position steady in Q1 2026 at 4,800 shares worth $577K. The position accounts for 0.32% of the portfolio, ranked #45.

Elefante Mark B first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Elefante Mark B held 4,800 shares of Merck worth $577K as of Q1 2026.
  • Elefante Mark B left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.32% of Elefante Mark B's portfolio in Q1 2026, its #45 holding.
  • Elefante Mark B first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Elefante Mark B's 13F filing for Q1 2026, filed 15 May 2026.